GENESIS Pharma Expands Alnylam Partnership into Nordic Region to Broaden Access to RNAi Therapies

The expanded partnership adds Denmark, Finland, Norway and Sweden to GENESIS Pharma’s existing network of thirteen Southeast European markets. ...

June 12, 2026 | Friday | News
Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy in Pancreatic Cancer Trial

Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, announc...

June 12, 2026 | Friday | News
Thermo Fisher Launches Chronic Hand Eczema Registry to Advance Real-World Evidence Generation

New registry will generate robust real-world evidence on disease burden, treatment patterns and long-term effectiveness of newly approved and emerging th...

June 12, 2026 | Friday | News
T-CURX Secures First Clinical Trial Approval for TCX-001, Advancing Novel Non-Viral CAR-T Therapy into the Clinic

Clinical Trial approval for TCX-001 is another significant development milestone for T-CURX and marks the transition of T-CURX from a pre-clinical to a...

June 12, 2026 | Friday | News
Lung Cancer Research Foundation and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment and Patient Advocacy

The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca,  announced that two research awards focused on improving outcomes for...

June 11, 2026 | Thursday | News
AcCELLerated Biologics Partners with Forever Labs to Expand Access to Stem Cell Banking and Personalized Regenerative Therapies

Leading regenerative medicine innovators unite to deliver seamless stem cell banking and personalized biologic solutions for physicians and patients nati...

June 11, 2026 | Thursday | News
Eli Lilly and Company Receives FDA Approval for Every-Eight-Week Maintenance Dosing of EBGLYSS in Atopic Dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the ...

June 11, 2026 | Thursday | News
Harbour BioMed Secures China IND Acceptance for HBM7004 in Advanced Solid Tumors

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics...

June 11, 2026 | Thursday | News
Phenomenex Launches Luna Omega HILIC LC Columns to Advance High-Performance Separation of Polar Compounds

Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, announced th...

June 10, 2026 | Wednesday | News
From Downtime to Digital Resilience: How Pharma Manufacturers Are Rethinking Spare Parts Strategy

As pharmaceutical manufacturers face increasing pressure to maintain production continuity, ensure regulatory compliance, and manage ageing equipment, the ...

June 10, 2026 | Wednesday | News
Made Scientific and Pluristyx Partner to Streamline iPSC Therapy Development and Manufacturing

Strategic partnership integrates Pluristyx's clinical-grade iPSC platform into Made Scientific's CDMO services, giving developers a single-source path fr...

June 09, 2026 | Tuesday | News
Lupin Secures U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec™

Global pharmaceutical leader Lupin Limited  announced that the United States Food and Drug Administration (U.S. FDA) has approved its ranibizum...

June 09, 2026 | Tuesday | News
Aragen Accelerates Daretabart Manufacturing Milestone for Renaissance Pharma Following FDA Fast Track Designation

Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has successfully tech-transferred and manufactured the fir...

June 09, 2026 | Tuesday | News
Sapio Sciences and ZS Partner to Accelerate Digital Laboratory Transformation in Biopharma

The partnership combines Sapio Platform capabilities with ZS consulting expertise to deliver integrated laboratory solutions Sapio Sciences, the AI lab i...

June 09, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close